Study of Niraparib and TSR-042 in Recurrent Endometrial Cancer
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03016338 |
|
Recruitment Status :
Active, not recruiting
First Posted : January 10, 2017
Last Update Posted : January 30, 2024
|
Sponsor:
University Health Network, Toronto
Collaborator:
Tesaro, Inc.
Information provided by (Responsible Party):
University Health Network, Toronto
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Active, not recruiting |
|---|---|
| Actual Primary Completion Date : | January 5, 2021 |
| Estimated Study Completion Date : | December 2025 |